lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12
Hepatocellular carcinoma (HCC) belongs to the most frequent cancer with a high death rate worldwide. Thousands of long non-coding RNAs (lncRNAs) have been confirmed to influence the development of human cancers, including HCC. Nevertheless, the biological role of PRR34 antisense RNA 1 (PRR34-AS1) in...
Saved in:
Main Authors: | Minzhen Qin (Author), Yiliang Meng (Author), Chunying Luo (Author), Shougao He (Author), Fengxue Qin (Author), Yixia Yin (Author), Junling Huang (Author), Hailiang Zhao (Author), Jing Hu (Author), Zhihua Deng (Author), Yiying Qiu (Author), Gaoyu Hu (Author), Hanhe Pan (Author), Zongshuai Qin (Author), Zansong Huang (Author), Tingzhuang Yi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
by: Yafei Wu, et al.
Published: (2020) -
Mechanism of sorafenib resistance associated with ferroptosis in HCC
by: Lingling Guo, et al.
Published: (2023) -
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022) -
PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
by: Sofie Olsson Hau, et al.
Published: (2022) -
MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?
by: Heng Li, et al.
Published: (2018)